The Man With The Golden Cells (2 of 5)

"There are fields...endless fields, were human beings are no longer born. We are grown." - Morpheus

part 1 - http://www.youtube.com/watch?v=R0o_a4OgOWM
part 3 - http://www.youtube.com/watch?v=NrHVMcKIUKs
part 4 - http://www.youtube.com/watch?v=6ExBT-DLxNg
part 5 - http://www.youtube.com/watch?v=-443s_UlXFk

Los Angeles, 1984: John Moore, a cancer patient, finds out that his doctor has cultivated, patented and sold his very rare golden cells, all without his awareness. So he takes his doctor to court. Guess what? The California Supreme Court decides that Moore cant really claim his body as his own. Bottom line: our cells, genesevery part of us can be bought and sold.

The Man with the Golden Cells travels the troubling road from John Moores case through to todays vibrant global trade of the human body: in Singapore, in Boston, in Paris, in Toronto, the very genes that make up the human body are there to be bought and sold.

Molecular biology, stem cells, genomics: these are the cutting-edge fields where the controversial work is happening. In The Man with the Golden Cells, something as sci-fi as the cloning of cell lines is just another FedEx delivery for the people who drive this industry.

The program begins with the extraordinary and shocking story of Moore, the man with the golden cells. We then travel from Europe to the U.S. via Canada, meeting players in and witnesses to the movement for the industrialization of human cells. The bioethical questions are disturbing to say the least

Its safe to say that we have gone a long way towards transforming ourselves into commodities, but how far is too far? Where should we set the limits? And who should decide? Or are our bodies just one more object to buy and sell? International in scope, The Man with the Golden Cells discovers that there is an entire industry out there thats not waiting for the decision to such difficult questions.

Its safe to say that humans have transformed themselves into merchandise, but to what extent should markets be allowed to exploit the human body? Should we set any limits? Or are our bodies just a new frontier to be explored and commodified? International in scope, The Man with the Golden Cells finds there are wildly different answers coming from around the world.

At the intersection between the demands of commerce, ethics and human health, the economics of profit are weighed against individual rights and our collective well-being. So, what does it mean to be human in the 21st century? Watch The Man with the Golden Cells for some thought-provoking answers: you might not like what you see.

The Man with the Golden Cells is directed by Florence Martin-Kessler, produced in association with 13 Production, ARTE France and the NFB. Michael Allder is Executive Producer for The Nature of Things.

http://www.cbc.ca/natureofthings/goldencells.html

Category:

Science & Technology

Tags:

• david
• suzuki
• biotech
• genes
• genomics
• cells
• greed
• corporatism
• private
• property
• global
• trade
• individuality

[DavidPennable]

Lori I get it but your wrong, it wasn't really about the money at all, it was about slowing people like me down, to level the playing field an informed individual with an understanding of morality, in a body that can act on that knowledge, they wanted to neutralize a prieceved threat, all based on ironically enough the exact polar opposite of their agenda.

[DavidPennable]

my response to 1:58, I would like to know before hand so I can say no, "your job is to make me better, it's people like you who drain health care resources. "

[sapumale]

naneedj.info I love being outdoors preferably

[PeteMcTeee]

Astonishing . . . A judge set precedent in a case tip toe'ing along eugenical lines in favor of big pharma.

Thesis - People are resources

Antithesis - I should be allowed to own this resource as property

Synthesis - The building blocks of humanity are simply that. Blocks. To be manipulated (for our benefit of course)

I can't wait to see how old Suzuki lays out this paradigm in part III